DE69622099T2 - Verfahren zur herstellung eines beta-lactamderivates - Google Patents

Verfahren zur herstellung eines beta-lactamderivates

Info

Publication number
DE69622099T2
DE69622099T2 DE69622099T DE69622099T DE69622099T2 DE 69622099 T2 DE69622099 T2 DE 69622099T2 DE 69622099 T DE69622099 T DE 69622099T DE 69622099 T DE69622099 T DE 69622099T DE 69622099 T2 DE69622099 T2 DE 69622099T2
Authority
DE
Germany
Prior art keywords
producing
beta lactam
lactam derivative
derivative
cephem derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69622099T
Other languages
English (en)
Other versions
DE69622099D1 (de
Inventor
Sigeru Torii
Hideo Tanaka
Michio Sasaoka
Yutaka Kameyama
Isao Wada
Yasuhisa Amano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Chemical Co Ltd
Original Assignee
Otsuka Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP07948795A external-priority patent/JP3791941B2/ja
Priority claimed from JP07949095A external-priority patent/JP3754990B2/ja
Application filed by Otsuka Chemical Co Ltd filed Critical Otsuka Chemical Co Ltd
Publication of DE69622099D1 publication Critical patent/DE69622099D1/de
Application granted granted Critical
Publication of DE69622099T2 publication Critical patent/DE69622099T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69622099T 1995-03-10 1996-03-08 Verfahren zur herstellung eines beta-lactamderivates Expired - Fee Related DE69622099T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP07948795A JP3791941B2 (ja) 1995-03-10 1995-03-10 3−ハロゲン化セフェム誘導体の製造法
JP07949095A JP3754990B2 (ja) 1995-03-10 1995-03-10 アレン化β−ラクタム化合物の製造方法
PCT/JP1996/000575 WO1996029334A1 (fr) 1995-03-10 1996-03-08 PROCEDE DE PREPARATION DE DERIVES DU β-LACTAME

Publications (2)

Publication Number Publication Date
DE69622099D1 DE69622099D1 (de) 2002-08-08
DE69622099T2 true DE69622099T2 (de) 2003-02-13

Family

ID=26420507

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69622099T Expired - Fee Related DE69622099T2 (de) 1995-03-10 1996-03-08 Verfahren zur herstellung eines beta-lactamderivates

Country Status (5)

Country Link
US (2) US5929233A (de)
EP (3) EP1201654B1 (de)
AT (2) ATE259786T1 (de)
DE (1) DE69622099T2 (de)
WO (1) WO1996029334A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996029334A1 (fr) * 1995-03-10 1996-09-26 Otsuka Kagaku Kabushiki Kaisha PROCEDE DE PREPARATION DE DERIVES DU β-LACTAME
FR2763333B1 (fr) * 1997-05-15 1999-06-25 Elf Aquitaine Procede de purification de dimethylsulfoxyde (dmso)
DE10151478C1 (de) * 2001-10-18 2003-03-13 Wacker Chemie Gmbh Mit Aminogruppen oberflächenmodifizierte Feststoffe, Verfahren zu deren Herstellung und deren Verwendung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH616685A5 (de) * 1974-07-05 1980-04-15 Fujisawa Pharmaceutical Co verfahren zur herstellung von neuen verbindungen der cephalosporinreihe
JP3195371B2 (ja) * 1991-03-11 2001-08-06 大塚化学株式会社 セフエム誘導体の製造法
US5162521A (en) * 1991-06-06 1992-11-10 Bristol-Myers Squibb Company Processes for making cephems from allenylazetidinone derivatives
US5162524B1 (en) * 1991-06-06 1997-06-17 Bristol Myers Squibb Co Processes for making cephems from allenylazetidinone derivatives
WO1996029334A1 (fr) * 1995-03-10 1996-09-26 Otsuka Kagaku Kabushiki Kaisha PROCEDE DE PREPARATION DE DERIVES DU β-LACTAME

Also Published As

Publication number Publication date
EP1201654A3 (de) 2002-05-08
WO1996029334A1 (fr) 1996-09-26
US5929233A (en) 1999-07-27
EP1201669A3 (de) 2002-05-08
DE69622099D1 (de) 2002-08-08
EP0759436A4 (de) 1998-11-25
ATE259786T1 (de) 2004-03-15
EP1201654A2 (de) 2002-05-02
EP1201669A2 (de) 2002-05-02
EP1201654B1 (de) 2004-02-18
EP0759436B1 (de) 2002-07-03
ATE220062T1 (de) 2002-07-15
US6150519A (en) 2000-11-21
EP0759436A1 (de) 1997-02-26

Similar Documents

Publication Publication Date Title
ATE157981T1 (de) Verfahren zur herstellung von kalium clavulanat
DE69826604D1 (de) Verfahren zur fermentativen herstellung von deacylierten cephalosporinen
EA199900334A1 (ru) Циклопентеноны, способы их получения и применение
DE3876303D1 (de) Verfahren zur herstellung eines duennschichttransistors.
DE69521175T2 (de) Verfahren zur Herstellung von Xanthangummi
DE69403210D1 (de) Verfahren zur herstellung von n-acetylneuraminsäure
DE3752226T2 (de) Ein Verfahren zur Herstellung eines 1-Amino-1-Deoxyoligosaccharid-Derivats
ATE240918T1 (de) Verfahren zur reduktion von carbonylverbindungen
DE69622099D1 (de) Verfahren zur herstellung eines beta-lactamderivates
DE69521415T2 (de) Verfahren zur herstellung eines clavulansäuresalzes
DE69106003D1 (de) Verfahren und zwischenprodukte zur herstellung von azabicyclo[2.2.2]octan-3-iminen.
SE9101431D0 (sv) A method for the preparation in a non-racemic form of furo (3,4-c) pyridine derivatives
DE69615204D1 (de) Verfahren zur herstellung von kaliumclavulanat
DE69520368T2 (de) Verfahren zur herstellung von 5-hydroxymethyl-thiazole
ATE229006T1 (de) Verfahren zur herstellung von schwefelhaltigen imidazolderivaten und erhaltene zwischenprodukte
DE69132091T2 (de) Verfahren zur Herstellung von Indolderivaten
ATE197293T1 (de) Verfahren zur herstellung von in 5-stellung substituierten 2-chlorpyridinen
ATA207094A (de) Verfahren zur herstellung von xanthangummi durch fermentation
ATE10281T1 (de) Verfahren zur herstellung eines antibiotikums.
DE69427148T2 (de) Verfahren zur Herstellung von 2,4,5-Tribrompyrrol-3-carbonitril
ATE394374T1 (de) Verfahren zur herstellung eines indolderivates
DE59501436D1 (de) Verfahren zur Herstellung von 2-Cyaniminothiazolidin
ATE190319T1 (de) Verfahren zur herstellung von plättchen-faktor-4
DE69306744D1 (de) Verfahren zur Herstellung von 2-aryl-5-trifluoro-methyl Pyrrole-Verbindungen
ATE175968T1 (de) Verfahren zur herstellung von kondensierten carbapenemderivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee